References
Traugott AL, Dehdashti F, Trinkaus K et al (2010) Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis. World J Surg 34:1247–1253
Fletcher JW, Djulbegovic B, Soares HP et al (2008) Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 49:480–508
Kim BH, Na MA, Kim IJ et al. (2010) Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation. Ann Nucl Med (Epub ahead). doi:10.1007/s12149-010-0414-60)
Mian C, Barollo S, Pennelli G et al (2008) Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake. Clin Endocrinol 68:108–116
Yasuda M, Ogane N, Hayashi H et al (2005) Glucose transporter-1 expression in the thyroid gland: clinicopathological significance for papillary carcinoma. Oncol Rep 14:1499–1504
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bertagna, F., Giubbini, R. Possible Role of F18-FDG-PET/CT in Differentiating Benign Lesions versus Malignant after Indeterminate Fine-needle Aspiration Cytology. A Wider and Still Controversial Issue. World J Surg 35, 1146–1147 (2011). https://doi.org/10.1007/s00268-010-0867-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-010-0867-8